You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 7,485,305


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,485,305
Title:Allergen from house-dust mites
Abstract: The present invention relates to a novel allergen from house-dust mites, to polypeptides derived from said allergen and polynucleotides encoding the same. Furthermore, the invention provides antibodies directed against the allergen and to the use of the polypeptides, polynucleotides and/or antibodies in therapy and diagnosis of allergic disorders.
Inventor(s): Valenta; Rudolf (Theresienfeld, AT), Valent; Peter (Vienna, AT), Weghofer; Margit (Vienna, AT), Vrtala; Susanne (Vienna, AT), Krauth; Maria-Theresia (Tribuswinkel, AT)
Assignee: Biomay AG (Vienna, AT)
Application Number:11/141,642
Patent Claims:1. An isolated polypeptide comprising the amino acid sequence shown in SEQ ID NO: 1.

2. An isolated polypeptide comprising the amino acids 20 to 140 shown in SEQ ID NO: 1.

3. An isolated polypeptide consisting of between 8 and 140 consecutive amino acid residues of SEQ ID NO:1 and, which in a rabbit model, induces IgG antibodies that do not cross-react with Dermatophagoides pteronyssinus (Der p) 2 or Der p 5.

4. The isolated polypeptide according to claim 3, which consists of between 18 and 140 consecutive amino acids of the amino acid sequence shown in SEQ ID NO: 1.

5. The isolated polypeptide of claim 3, which consists of between 21 and 140 consecutive amino acids of SEQ ID NO:1.

6. The isolated polypeptide of claim 3, which consists of between 25 and 140 consecutive amino acids of SEQ ID NO:1.

7. The isolated polypeptide of claim 3, which consists of between 35 and 140 consecutive amino acids of SEQ ID NO:1.

8. The isolated polypeptide of claim 3, which consists of between 50 and 140 consecutive amino acids of SEQ ID NO:1.

9. The isolated polypeptide of claim 3, which consists of between 8 and 100 consecutive amino acids of SEQ ID NO:1.

10. A protein fusion comprising the polypeptide of one of claims 1, 2, or 3.

11. A pharmaceutical composition comprising the polypeptide according to one of claims 1, 2, or 3 and one or more pharmaceutically acceptable carriers, diluents, vehicles or adjuvants.

12. A diagnostic kit comprising a container and the polypeptide according to one of claims 1, 2, or 3.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.